Atlas Trials

Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients

Clinical trial NCT01612078 · TERMINATED

Trial details

NCT number
NCT01612078
Sponsor
TSH Biopharm Corporation Limited
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Orthostatic Hypotension
Start date
2012-06-01
Primary completion
2013-02-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.